<p>* except where indicated otherwise, values are the number (%) of patients. SLE = Systemic Lupus Erythematosus; SELENA-SLEDAI = Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA) version of the SLE Disease Activity Index (SLEDAI).</p><p><sup>†</sup> Excluding antimalarial and prednisone.</p><p>Baseline characteristics and disease parameters of the SLE patients<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0143689#t001fn001" target="_blank">*</a></sup>.</p
Systemic Lupus Erythematosus (SLE), because of its complex and multisystemic presentation, lacks a r...
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple organ involvem...
Objective. Improved standards for the evaluation of therapeutic interventions in systemic lupus eryt...
<p>CAD, coronary artery disease; BMI, body mass index; SELENA, safety of estrogens in lupus erythema...
<p>*Except when otherwise indicated, values are expressed as counted data (%). SLEDAI-2K: Systemic L...
Objective: To report baseline data of SLE patients enrolled in the Lupus Italian Registry (LIRE). Me...
<p>Values are median (interquartile range, IQR) unless stated otherwise; s.d., standard deviation; n...
<p>SLE—systemic lupus erythematosus, SLEDAI—SLE disease activity index, ANA- nuclear antibodies, dsD...
Objective: To report baseline data of SLE patients enrolled in the Lupus Italian Registry (LIRE). ...
<p>SD: standard deviation; IQR: interquartile range; CIMT: carotid intima media thickness; aCL: anti...
<p>SD: Standard Deviation; NP: NeuroPsychiatric; SLEDAI: Systemic Lupus Erythematosus Disease Activi...
<p>SD: Standard Deviation; NP: NeuroPsychiatric; SLEDAI: Systemic Lupus Erythematosus Disease Activi...
*<p>Values are shown by mean ± SEM (range) or number (percentage). There were no significant differe...
a<p>Data from >98% of the patients for all characteristics except for the following: malar rash, neu...
<p>Note: SLEDAI: Systemic Lupus Erythematosus Disease Activity Index</p><p>Clinical and pathological...
Systemic Lupus Erythematosus (SLE), because of its complex and multisystemic presentation, lacks a r...
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple organ involvem...
Objective. Improved standards for the evaluation of therapeutic interventions in systemic lupus eryt...
<p>CAD, coronary artery disease; BMI, body mass index; SELENA, safety of estrogens in lupus erythema...
<p>*Except when otherwise indicated, values are expressed as counted data (%). SLEDAI-2K: Systemic L...
Objective: To report baseline data of SLE patients enrolled in the Lupus Italian Registry (LIRE). Me...
<p>Values are median (interquartile range, IQR) unless stated otherwise; s.d., standard deviation; n...
<p>SLE—systemic lupus erythematosus, SLEDAI—SLE disease activity index, ANA- nuclear antibodies, dsD...
Objective: To report baseline data of SLE patients enrolled in the Lupus Italian Registry (LIRE). ...
<p>SD: standard deviation; IQR: interquartile range; CIMT: carotid intima media thickness; aCL: anti...
<p>SD: Standard Deviation; NP: NeuroPsychiatric; SLEDAI: Systemic Lupus Erythematosus Disease Activi...
<p>SD: Standard Deviation; NP: NeuroPsychiatric; SLEDAI: Systemic Lupus Erythematosus Disease Activi...
*<p>Values are shown by mean ± SEM (range) or number (percentage). There were no significant differe...
a<p>Data from >98% of the patients for all characteristics except for the following: malar rash, neu...
<p>Note: SLEDAI: Systemic Lupus Erythematosus Disease Activity Index</p><p>Clinical and pathological...
Systemic Lupus Erythematosus (SLE), because of its complex and multisystemic presentation, lacks a r...
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple organ involvem...
Objective. Improved standards for the evaluation of therapeutic interventions in systemic lupus eryt...